Leslie Clifton
Medical · Stuart, FLNPI 1437485828
Payments from drug & device makers
Across 383 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Actelion Pharmaceuticals US, Inc.$1K
- Philips North America LLC$819
- United Therapeutics Corporation$687
- Boehringer Ingelheim$580
- GSK$538
- plus $3K from 26 others
What the payments were for
- Food & beverage$8,66898%
- Education$1342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 75 | $1,693 |
| Actelion Pharmaceuticals US, Inc. | 32 | $1,030 |
| Philips North America LLC | 41 | $819 |
| United Therapeutics Corporation | 18 | $687 |
| Boehringer Ingelheim | 34 | $580 |
| GSK | 30 | $538 |
| Amgen | 15 | $534 |
| Insmed, Inc. | 18 | $433 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $423 |
| Electromed, Inc. | 17 | $267 |
| Regeneron Healthcare Solutions, Inc. | 9 | $266 |
| Baxter Healthcare | 14 | $225 |
| Mylan Specialty L.p. | 8 | $174 |
| Inogen, Inc. | 15 | $172 |
| Merck | 5 | $123 |
| Pfizer | 5 | $116 |
| Novartis | 5 | $115 |
| Mallinckrodt Hospital Products Inc. | 5 | $101 |
| Verona Pharma, Inc. | 4 | $97 |
| Grifols USA, LLC | 2 | $58 |
| Johnson & Johnson | 3 | $49 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Melinta Therapeutics, LLC | 2 | $43 |
| Genentech USA, Inc. | 2 | $42 |
| Sanofi | 2 | $35 |
| Advanced Respiratory, Inc | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Resmed Corp | 1 | $20 |
| Olympus America Inc. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Pulmonx Corporation | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,802 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 16 | $214,235 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 163 | $183,992 |
| NucalaMepolizumab | 25 | $92,513 |
| Breo ElliptaFluticasone/Vilanterol | 62 | $38,394 |
| XareltoRivaroxaban | 18 | $18,491 |
| Spiriva RespimatTiotropium Bromide | 18 | $18,290 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $16,911 |
| EliquisApixaban | 14 | $15,590 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $4,917 |
| Arnuity ElliptaFluticasone Furoate | 14 | $3,819 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,737 |
| Montelukast Sodium | 125 | $1,300 |
| Ventolin HfaAlbuterol Sulfate | 15 | $866 |
| Prednisone | 124 | $712 |
| Fluticasone Propionate | 34 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Arnuity Ellipta | $538 | $318,718264 claims |
| Boehringer IngelheimOfev, Spiriva Respimat | $580 | $232,52534 claims |
| Johnson & JohnsonXarelto | $49 | $18,49118 claims |
| AstraZenecaBreztri Aerosphere | $1,693 | $16,91120 claims |
| PfizerEliquis | $116 | $15,59014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.
Other medical in Stuart
- Elizabeth ChobyStuart$16K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.